On July 29th, Gese Bio announced a strategic collaboration with Porton Pharma Solutions (300363) subsidiary Porton Bio for their respective advantages in the field of gene therapy. Through the strong alliance, the two parties will jointly develop drug development services. Gese Bio has more complete core patent technology in the concept verification and process development of circRNA drugs, combined with Porton Bio's end-to-end gene and cell therapy service platform and resource advantages, to jointly promote technological innovation and clinical transformation, accelerate the landing of circRNA innovative therapy.
- Latest
- Detail
博腾生物与吉赛生物达成战略合作，聚力推进circRNA创新疗法
BoTeng Biology and Gese Biology have reached a global strategy cooperation to jointly promote innovative circRNA therapies.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.